SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-20-000037
Filing Date
2020-03-04
Accepted
2020-03-04 16:08:09
Documents
4
Period of Report
2020-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2019_earningsxrelease.htm 8-K 30549
2 EXHIBIT 99.1 opnt_4qfy19financialresult.htm EX-99.1 25203
3 opnt4qfy19financialre_image1.gif GRAPHIC 183134
4 opnt4qfy19financialre_image2.gif GRAPHIC 142686
  Complete submission text file 0001385508-20-000037.txt   506244
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 20687204
SIC: 1000 Metal Mining